Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMYD3 | Q9H7B4 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.37 |
| ▸ | CA6 | P23280 | 3/20 | 0.37 |
| ▸ | CA7 | P43166 | 3/20 | 0.37 |
| ▸ | CA9 | Q16790 | 3/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA3 | P07451 | 2/20 | 0.35 |
| ▸ | CA4 | P22748 | 2/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.35 |
| ▸ | SQLE | Q14534 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4514731 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL30606551 | 0.97 | — | — | |
| SCHEMBL10064482 | 0.91 | — | — | |
| SCHEMBL8489099 | 0.91 | — | — | |
| SCHEMBL14643941 | 0.89 | SMYD3 (0.37) | SMYD3CA12CA6CA7CA9 | |
| SCHEMBL23016010 | 0.88 | KDM4E (0.46) | ALDH1A1RAD52KDM4ECXCR4CXCL12 | |
| SCHEMBL1913633 | 0.88 | KDM4E (0.46) | ALDH1A1RAD52KDM4ECXCR4CXCL12 | |
| SCHEMBL13801723 | 0.88 | KDM4E (0.46) | ALDH1A1RAD52KDM4ECXCR4CXCL12 | |
| SCHEMBL24029510 | 0.88 | KDM4E (0.46) | ALDH1A1RAD52KDM4ECXCR4CXCL12 | |
| Hydrochloric Acid SCHEMBL31720531 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2734507-B1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | ALLNEX IP S À R L (LU) | 2017-05-31 | — | — | EP | disclosed |
| US-9440928-B2 | Process for the synthesis of N-substituted cyclic alkylene ureas | Allnex IP S.ar.L. (LU) | 2016-09-13 | — | — | US | disclosed |
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | ALLNEX USA INC. (US) | 2014-06-26 | — | — | US | disclosed |
| EP-2734507-A1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | Allnex IP S.à.r.l. (LU) | 2014-05-28 | — | — | EP | disclosed |
| WO-2013012995-A1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | CYTEC TECHNOLOGY CORP. (US) | 2013-01-24 | — | — | WO | disclosed |
| EP-2548869-A1 | Process for the Synthesis of N-substituted Cyclic Alkylene Ureas | Cytec Technology Corp. (US) | 2013-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179931-A1 | Process for the Synthesis of N-Substituted Cyclic Alkylene Ureas | CA4, CA2, CDYL | SMYD3 1695/4885CA12 5/4885CA6 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.